Aurinia Pharmaceuticals Inc Capital Reinvestment Ratio
Aurinia Pharmaceuticals Inc capital reinvestment ratio. Aurinia Pharmaceuticals Inc (AUPH) has a Capital Reinvestment Ratio of 0.00x as of June 2026, meaning it reinvests 0% of its operating cash flow ($52.17 Million) in capital expenditures ($179.00). Check AUPH total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Aurinia Pharmaceuticals Inc (2024–2025)
Capital reinvestment ratio of Aurinia Pharmaceuticals Inc from 2024 to 2025. This chart tracks Aurinia Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore AUPH net assets growth trend to track the company's year-over-year net asset growth rate.
Aurinia Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2024–2025)
Aurinia Pharmaceuticals Inc capital reinvestment ratio by year from 2024 to 2025. For the full cash flow conversion analysis, see Aurinia Pharmaceuticals Inc (AUPH) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $135.66 Million | $252.00K | ▼ -70.7% |
| 2024 | 0.01x | $44.39 Million | $281.00K | — |